Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - Is retransfusion of pericardial blood harmful?

Perfusion

Volumn 26, Issue 1, 2011, Pages 21-29

  Biro E ^a   Van Den Goor, J M ^a   De Mol, B A ^a   Schaap, M C ^a   Ko, L Y ^a   Sturk, A ^a   Hack, C E ^b   Nieuwland, R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SERUM AMYLOID P;

ARTERIAL BLOOD; ARTICLE; BLOOD; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART SURGERY; HUMAN; MEMBRANE MICROPARTICLE; PERICARDIUM; PRIORITY JOURNAL;

BLOOD TRANSFUSION, AUTOLOGOUS; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CELL-DERIVED MICROPARTICLES; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN M; PERICARDIUM; SERUM AMYLOID P-COMPONENT;

EID: 78650671426     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659110385742     Document Type: Article

References (31)

1. Paparella D., Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002 ; 21: 232-244.
2. Levy JH, Tanaka KA Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003 ; 75: S715 - S720.
3. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002 ; 123: 742-755.
4. Chenoweth DE, Cooper SW, Hugli TE et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981 ; 304: 497-503.
5. Bruins P., te Velthuis H., Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997 ; 96: 3542-3548.
6. Cavarocchi NC, Schaff HV, Orszulak TA, et al. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 1985 ; 98: 525-531.
7. de Haan J., Boonstra PW, Monnink SH, Ebels T., van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995 ; 59: 901-907.
8. Westerberg M., Bengtsson A., Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004 ; 78: 54-59.
9. Nieuwland R., Berckmans RJ, Rotteveel-Eijkman RC, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997 ; 96: 3534-3541.
10. VanWijk MJ, VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003 ; 59: 277-287.
11. Nauta AJ, Trouw LA, Daha MR, et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002 ; 32: 1726-1736.
12. Law SK, Lichtenberg NA, Levine RP Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol 1979 ; 123: 1388-1394.
13. Campbell RD, Dodds AW, Porter RR The binding of human complement component C4 to antibody-antigen aggregates. Biochem J 1980 ; 189: 67-80.
14. Biró I., Nieuwland R., Tak PP, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 2007 ; 66: 1085-1092.
15. Biró I., Lok CA, Hack CE, et al. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta 2007 ; 28: 928-935.
16. Kaplan MH, Volanakis JE Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 1974 ; 112: 2135-2147.
17. Füst G., Medgyesi GA, Rajnavölgyi E., et al. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1. Immunology 1978 ; 35: 873-884.
18. Ying SC, Gewurz AT, Jiang H., Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J Immunol 1993 ; 150: 169-176.
19. Kim SJ, Gershov D., Ma X., Brot N., Elkon KB I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002 ; 196: 655-665.
20. van den Goor JM, Nieuwland R., Rutten PM, et al. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. Eur J Cardiothorac Surg 2007 ; 31: 1029-1036.
21. Wolbink GJ, Bollen J., Baars JW, et al. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 1993 ; 163: 67-76.
22. Familian A., Zwart B., Huisman HG, et al. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J Immunol 2001 ; 167: 647-654.
23. Biró I., Nieuwland R., Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004 ; 2: 1843-1844.
24. Hack CE, Paardekooper J., Smeenk RJ, et al. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J Immunol 1988 ; 141: 1602-1609.
25. Hoekzema R., Martens M., Brouwer MC, Hack CE The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol Immunol 1988 ; 25: 485-494.
26. Wolbink GJ, Brouwer MC, Buysmann S., Ten Berge IJ, Hack CE CRP-mediated activation of complement in vivo: assessment by measuring circulating complementC-reactive protein complexes. J Immunol 1996 ; 157: 473-479.
27. Biró I., Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003 ; 1: 2561-2568.
28. Takizawa F., Tsuji S., Nagasawa S. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett 1996 ; 397: 269-272.
29. Mevorach D., Mascarenhas JO, Gershov D., Elkon KB Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998 ; 188: 2313-2320.
30. Miyanishi M., Tada K., Koike M., et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007 ; 450: 435-439.
31. Rand ML, Wang H., Bang KW, Packham MA, Freedman J. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 2006 ; 4: 1621-1623.